Peer Review reports
From: Clinical application of serum tumor abnormal protein in prostate cancer patients
| Original Submission | ||
|---|---|---|
| 28 Oct 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 19 Nov 2023 | Reviewed | Reviewer Report - Erdal Benli |
| 25 Mar 2024 | Reviewed | Reviewer Report |
| 4 Apr 2024 | Author responded | Author comments - Yachen Zang |
| Resubmission - Version 3 | ||
| 4 Apr 2024 | Submitted | Manuscript version 3 |
| 14 Apr 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 23 May 2024 | Editorially accepted | |
| 31 May 2024 | Article published | 10.1186/s12885-024-12418-z |
You can find further information about peer review here.